Showing 3801-3810 of 7373 results for "".
- 8th Annual CSF Meeting Kicks Offhttps://practicaldermatology.com/news/8th-annual-csf-meeting-kicks-off/2458356/The Cosmetic Surgery Forum (CSF), now in its eighth year, was founded by NE-based dermatologist Joel Schlessinger, MD. CSF is a three-day multi-specialty educational symposium that covers the latest research, treatment and techniques in dermatology and cosmetic surgery. Unlike other meetings, res
- Patient Enrollment Complete in Phase 3 Acne Trials for Minocycline Foam FMX101https://practicaldermatology.com/news/patient-enrollment-complete-in-phase-3-acne-trials-for-minocycline-foam-fmx101/2458357/Patient enrollment is now complete for two Phase 3 clinical trials evaluating the efficacy and safety of FMX101, a topical 4 percent minocycline foam for the treatment of moderate-to-severe acne, according to Foamix Pharmaceuticals Ltd. Foamix is con
- ASDS Honors Awarded and New Board Members Electedhttps://practicaldermatology.com/news/asds-honors-and-new-board-members/2458362/Four members of the American Society for Dermatologic Surgery (ASDS) recently were recognized with the President’s Award for their extraordinary contributions to the Society or the specialty as a whole, and the ASDS awarded Jeanean D. Carruthers, MD, of Vancouver, British Columbia, Canada,
- ADAM Accepting Nominations for Practice Manager of the Yearhttps://practicaldermatology.com/news/adam-accepting-nominations-for-practice-manager-of-the-year/2458363/The Association of Dermatology Administrators and Managers is accepting nominations for its annual Practice Manager of the Year Award. Now in its fourth year, the Practice Manager of the Year Award recognizes the office professional who best demonstrates innovative thinking, ins
- Study: Anxiety, Depression May Travel with Hyperhidrosishttps://practicaldermatology.com/news/anxiety-depression-may-travel-with-hyperhidrosis/2458367/Individuals with hyperhidrosis are more likely to be anxious or depressed than their colleagues who don’t sweat excessively, new research suggests. Specifically, the prevalence of anxiety and depression was 21.3 percent and 27.2 percent in patients with hyperhidrosis, resp
- Merz On The Move: Reflections On Fiscal Year 2015/16https://practicaldermatology.com/news/merz-on-the-move-reflections-on-fiscal-year-201516/2458365/Merz Pharma’s core business has grown by 8.9 percent from EUR 809.8 million to EUR 881.9 million in fiscal 2015/16, the company reports. The company’s total revenue of EUR 1,092.9 million has declined by 5.5 percent compared to previous year
- Office Job, Stress And Diet May Increase Risk of Adult Acnehttps://practicaldermatology.com/news/office-job-stress-diet-may-increase-risk-of-adult-acne/2458370/Lifestyle factors -- including stress -- may play a role in adult acne development, a new study suggests. Researchers in Italy compared 248 women diagnosed with adult acne to 270 women without acne. They found that adult acne was associated with a personal history of acne in adolesce
- New from Topix: Replenix® Pure Hydration Moisture Balmhttps://practicaldermatology.com/news/new-from-topix-replenix-pure-hydration-moisture-balm/2458368/The latest from Topix Pharmaceuticals, Inc., Replenix® Pure Hydration Moisture Balm, targets dry and aging skin. Various molecular weights of Hyaluronic Acid draw moisture into the skin and work with Yucca Glauca
- Derms Commonly Misdiagnose Fungal Skin Infectionshttps://practicaldermatology.com/news/fungal-skin-infections-commonly-misdiagnosed/2458372/Fungal skin infections may be commonly misdiagnosed, according to a survey in the Journal of the American Academy of Dermatology. George Washington University (GW) dermatologist Adam Friedman, MD and colleag
- Two New Studies Suggest BPX-01 Topical Minocycline May Hold Advantageshttps://practicaldermatology.com/news/two-new-studies-suggest-bpx-01-topical-minocycline-may-hold-advantages/2458376/Taken together, two new studies suggest that BioPharmX Corp.’s BPX-01 topical minocycline may have a favorable pharmacokinetic advantage compared with oral minocycline for the treatment of acne vulgaris. The research was at the Skin Disease Edu